{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:04:43Z","timestamp":1757541883591},"reference-count":57,"publisher":"Impact Journals, LLC","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,25]]},"DOI":"10.18632\/oncotarget.11829","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T18:18:30Z","timestamp":1472840310000},"page":"69565-69578","source":"Crossref","is-referenced-by-count":11,"title":["Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma"],"prefix":"10.18632","volume":"7","author":[{"given":"Shenqi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yipeng","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Tumor Pathology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan Hwu","family":"Chew","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Akatsuka","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Tumor Pathology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Sekido","sequence":"additional","affiliation":[{"name":"Department of Cancer Genetics, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"},{"name":"Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Yokoi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Toyokuni","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"1","volume-title":"Pathology of asbestos-associated diseases","author":"Sporn","year":"2004"},{"key":"2","first-page":"1","article-title":"Mechanisms of asbestos-induced carcinogenesis","volume":"71","author":"Toyokuni","year":"2009","journal-title":"Nagoya J Med Sci"},{"key":"3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.freeradbiomed.2015.05.002","article-title":"Malignant mesothelioma as an oxidative stress-induced cancer:An update","volume":"86","author":"Toyokuni","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"5","first-page":"219","volume-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans A Review of Human Carcinogens; Part C:Arsenic, Metals, Fibres, and Dusts","author":"IARC, WHO","year":"2012"},{"key":"6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Lake","year":"2005","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Sorahan","year":"2011","journal-title":"Bull World Health Organ"},{"key":"8","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1200\/JCO.2011.41.5869","article-title":"Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine\/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma","volume":"30","author":"Brahmer","year":"2012","journal-title":"J Clin Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-5793(94)00674-1","article-title":"Structure\u2014function relationships in the receptor for urokinase-type plasminogen activator Comparison to other members of the Ly\u20136 family and snake venom \u03b1\u2013neurotoxins","volume":"349","author":"Ellis","year":"1994","journal-title":"FEBS Lett"},{"key":"10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajcp\/102.6.835","article-title":"Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue","volume":"102","author":"Dan\u00f8","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/1523-1747.ep12373187","article-title":"The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds","volume":"102","author":"Dan\u00f8","year":"1994","journal-title":"J Invest Dermatol"},{"key":"12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ctrv.2007.10.005","article-title":"Evolving role of uPA\/uPAR system in human cancers","volume":"34","author":"Sarkar","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"13","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0021-9258(18)52382-6","article-title":"Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol","volume":"266","author":"Dano","year":"1991","journal-title":"J Biol Chem"},{"key":"14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200701092","article-title":"uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells","volume":"178","author":"Gonias","year":"2007","journal-title":"J Cell Biol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1160\/TH10-02-0101","article-title":"Urokinase-type plasminogen activator receptor is associated with the development of adipose tissue","volume":"104","author":"Matsuo","year":"2010","journal-title":"Thromb Haemost"},{"key":"16","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1158\/1078-0432.CCR-07-4863","article-title":"Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy","volume":"14","author":"Mazar","year":"2008","journal-title":"Clin Cancer Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.18632\/oncotarget.1754","article-title":"The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style","volume":"5","author":"Del Rosso","year":"2014","journal-title":"Oncotarget"},{"key":"18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/med.10054","article-title":"Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer","volume":"24","author":"Wang","year":"2004","journal-title":"Med Res Rev"},{"key":"19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1165\/rcmb.2008-0433OC","article-title":"The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells","volume":"42","author":"Idell","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1525-1438.1998.09818.x","article-title":"Urokinase-type plasminogen activator in epithelial ovarian cancer: a poor prognostic factor, associated with advanced stage","volume":"8","author":"Carcangiu","year":"1998","journal-title":"Int J Gynecol Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer","volume":"24","author":"Testa","year":"2005","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/sj.onc.1205342","article-title":"Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells","volume":"21","author":"Aguirre Ghiso","year":"2002","journal-title":"Oncogene"},{"key":"23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.leu.2402824","article-title":"Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy","volume":"17","author":"McCubrey","year":"2003","journal-title":"Leukemia"},{"key":"24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Gustafson","year":"2016","journal-title":"Nat Genet"},{"key":"25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/path.4075","article-title":"Iron overload signature in chrysotile-induced malignant mesothelioma","volume":"228","author":"Hirano","year":"2012","journal-title":"J Pathol"},{"key":"26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.4377","article-title":"Connective tissue growth factor and beta-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma","volume":"233","author":"Toyokuni","year":"2014","journal-title":"J Pathol"},{"key":"27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1165\/ajrcmb.21.5.3225","article-title":"Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells","volume":"21","author":"Idell","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2821","article-title":"Regulation of cell signalling by uPAR","volume":"11","author":"Marshall","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"29","first-page":"4671","article-title":"Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue","volume":"54","author":"Grondahl-Hansen","year":"1994","journal-title":"Cancer Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s12032-011-9993-x","article-title":"Role of urokinase plasminogen activator receptor (CD87) as a prognostic marker in acute myeloid leukemia","volume":"29","author":"El Shabrawy","year":"2012","journal-title":"Med Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2796.2010.02284.x","article-title":"Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening","volume":"269","author":"Tornblom","year":"2011","journal-title":"J Intern Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.canlet.2006.03.003","article-title":"The prognostic value of the topographic distribution of uPAR expression in invasive breast carcinomas","volume":"246","author":"Nakopoulou","year":"2007","journal-title":"Cancer Lett"},{"key":"33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1083\/jcb.200612058","article-title":"uPAR-induced cell adhesion and migration: vitronectin provides the key","volume":"177","author":"Sidenius","year":"2007","journal-title":"The Journal of cell biology"},{"key":"34","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1083\/jcb.152.6.1145","article-title":"Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin","volume":"152","author":"Hall","year":"2001","journal-title":"J Cell Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1165\/rcmb.2011-0071OC","article-title":"Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells","volume":"46","author":"Idell","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4161\/cc.10.1.14362","article-title":"Downregulation of uPAR inhibits migration, invasion, proliferation, FAK\/PI3K\/Akt signaling and induces senescence in papillary thyroid carcinoma cells","volume":"10","author":"Geliebter","year":"2011","journal-title":"Cell Cycle"},{"key":"37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Cantley","year":"2007","journal-title":"Cell"},{"key":"38","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival: a play in three Akts","volume":"13","author":"Greenberg","year":"1999","journal-title":"Gene Dev"},{"key":"39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1535-6108(02)00072-7","article-title":"EGFR is a transducer of the urokinase receptor initiated signal that is required forgrowth of a human carcinoma","volume":"1","author":"Ossowski","year":"2002","journal-title":"Cancer Cell"},{"key":"40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1073\/pnas.022652999","article-title":"The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1\/LXA4R","volume":"99","author":"Blasi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"41","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.4161\/cc.28921","article-title":"Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis","volume":"13","author":"Huang","year":"2014","journal-title":"Cell Cycle"},{"key":"42","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1371\/journal.pone.0000243","article-title":"Identification of uPAR-positive chemoresistant cells in small cell lung cancer","volume":"2","author":"Aboody","year":"2007","journal-title":"PLoS One"},{"key":"43","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"44","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1101\/gad.11.6.701","article-title":"The PI 3-kinase\/Akt signaling pathway delivers an anti-apoptotic signal","volume":"11","author":"Hay","year":"1997","journal-title":"Gene Dev"},{"key":"45","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1158\/0008-5472.CAN-05-0425","article-title":"Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway","volume":"66","author":"Tsang","year":"2006","journal-title":"Cancer Res"},{"key":"46","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbrc.2010.03.029","article-title":"Role of the Akt\/mTOR survival pathway in cisplatin resistance in ovarian cancer cells","volume":"394","author":"Wu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"47","first-page":"1843","article-title":"The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients","volume":"58","author":"Br\u00fcnner","year":"1998","journal-title":"Cancer Res"},{"key":"48","first-page":"972587","article-title":"Association of tissue mRNA and serum antigen levels of members of the urokinase-type plasminogen activator system with clinical and prognostic parameters in prostate cancer","volume":"2014","author":"Baretton","year":"2014","journal-title":"Biomed Res Int"},{"key":"49","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cncr.25555","article-title":"Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma","volume":"117","author":"Alexander","year":"2011","journal-title":"Cancer"},{"key":"50","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/0008-5472.CAN-12-3526","article-title":"Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer","volume":"73","author":"Craik","year":"2013","journal-title":"Cancer Res"},{"key":"51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3164\/jcbn.10-01","article-title":"A novel method for efficient collection of normal mesothelial cells","volume":"46","author":"Toyokuni","year":"2010","journal-title":"J Clin Biochem Nutr"},{"key":"52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","article-title":"Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients","volume":"97","author":"Hida","year":"2006","journal-title":"Cancer Sci"},{"key":"53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/onc.2013.528","article-title":"LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade","volume":"34","author":"Sekido","year":"2015","journal-title":"Oncogene"},{"key":"54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/labinvest.2009.140","article-title":"Homozygous deletion of CDKN2A\/2B is a hallmark of iron-induced high-grade rat mesothelioma","volume":"90","author":"Toyokuni","year":"2010","journal-title":"Lab Invest"},{"key":"55","doi-asserted-by":"crossref","first-page":"E1330","DOI":"10.1073\/pnas.1110013108","article-title":"Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis","volume":"108","author":"Takahashi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/carcin\/bgt267","article-title":"Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production","volume":"35","author":"Toyokuni","year":"2014","journal-title":"Carcinogenesis"},{"key":"57","first-page":"4244s","article-title":"Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors","volume":"46","author":"McCarty","year":"1986","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T17:14:35Z","timestamp":1657214075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":57,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2016,10,25]]}},"alternative-id":["11829","27602956"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11829","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]}}}